CD274 and gastric cancer: For these reasons, other noninvasive methods, such as 18F-FDG PET/CT, which could predict the expression of PD-L1/PD-L1-TILs and inform optimal treatment decision with anti-PD-L1 antibodies would be of important clinical value in gastric cancer patients.